SynthesisJournal for immunotherapy of cancer2019

Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials.

Jia-Wei Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.